Complete Filing Data
SBC Medical Group Holdings Inc reported Net Income Loss of $50.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SBC Medical Group Holdings Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $51.0M | $46.6M | $39.4M | |
| Operating Income Loss | $67.5M | $70.3M | $70.7M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $82.1M | $73.5M | $73.6M | |
| Income Tax Expense Benefit | $31.0M | $26.8M | $35.0M | |
| Operating Expenses | $59.8M | $85.7M | $66.6M | |
| Accrued Income Taxes Current | $8.8M | $18.7M | $8.8M | $248.5K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$2.9M | -$16.6M | -$12.9M | |
| Selling General And Administrative Expense | $59.8M | $57.7M | $66.2M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $173.6M | $205.4M | $193.5M | |
| Other Nonoperating Income | $5.1M | $3.9M | $3.6M | |
| Other Nonoperating Expense | $1.3M | $5.5M | $745.5K | |
| Nonoperating Income Expense | $14.6M | $3.2M | $2.9M | |
| Net Income Loss Attributable To Noncontrolling Interest | $59.4K | $75.6K | -$809.4K | |
| Interest Expense Nonoperating | $160.6K | $28.3K | $45.3K | |
| Gross Profit | $127.3M | $156.1M | $137.3M | |
| Cost Of Revenue | $46.3M | $49.4M | $56.2M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $48.1M | $30.1M | $25.7M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $225.7K | $117.8K | -$948.9K | |
| Comprehensive Income Net Of Tax | $47.9M | $30.0M | $26.6M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.9M | -$16.6M | -$12.9M | |
| Income Taxes Paid Net | $37.2M | $30.2M | $17.8M | |
| Deferred Income Taxes And Tax Credits | $5.3M | -$14.4M | $4.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $12.8M | $2.5M | $21.5M | $2.8M | $18.5M | $18.8M | $8.4M | $196.8K | $613.3K | -$11.4K | -$1.3K | -$339.00 |
| Operating Income Loss | $15.9M | $14.6M | $24.2M | $13.8M | $27.3M | $24.5M | $20.0M | -$473.4K | -$388.4K | -$303.6K | -$1.3K | -$339.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $18.5M | $13.5M | $31.5M | $13.1M | $27.1M | $27.2M | $21.1M | $363.5K | $876.0K | $47.2K | -$1.3K | -$339.00 |
| Income Tax Expense Benefit | $5.7M | $11.1M | $10.0M | $10.3M | $8.5M | $8.5M | $13.0M | $166.7K | $262.7K | $58.7K | ||
| Operating Expenses | $14.7M | $15.5M | $13.5M | $29.4M | $12.1M | $15.1M | $13.5M | $430.8K | $374.5K | $177.9K | $1.3K | $339.00 |
| Accrued Income Taxes Current | $766.8K | $14.1M | $1.6M | $8.0M | $2.0K | $56.5K | $7.9K | $511.2K | $58.7K | |||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$6.8M | $8.6M | $9.8M | $20.8M | -$9.0M | -$10.2M | -$974.2K | -$7.9M | -$11.0M | |||
| Selling General And Administrative Expense | $14.7M | $15.5M | $13.5M | $16.6M | $12.1M | $15.1M | $13.4M | |||||
| Revenue From Contract With Customer Excluding Assessed Tax | $43.4M | $43.4M | $47.3M | $53.1M | $53.1M | $54.8M | $47.3M | |||||
| Other Nonoperating Income | $2.5M | $33.8K | $151.3K | $65.9K | $306.3K | $349.7K | $1.1M | |||||
| Other Nonoperating Expense | $6.6K | $1.1M | $1.7M | $795.2K | $514.6K | $1.4M | $98.3K | |||||
| Nonoperating Income Expense | $2.6M | -$1.0M | $7.2M | -$726.8K | -$204.1K | $2.7M | $1.0M | |||||
| Net Income Loss Attributable To Noncontrolling Interest | $8.7K | -$18.4K | -$10.5K | $1.6K | $72.9K | -$7.5K | -$298.6K | |||||
| Interest Expense Nonoperating | $48.6K | $49.7K | $6.2K | $5.5K | $7.4K | $3.0K | $4.0K | |||||
| Gross Profit | $30.6M | $30.0M | $37.7M | $43.2M | $39.4M | $39.5M | $33.5M | |||||
| Cost Of Revenue | $12.7M | $13.3M | $9.6M | $9.8M | $13.7M | $15.3M | $13.8M | |||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.0M | $11.1M | $31.3M | $23.6M | $9.5M | $8.6M | $6.9M | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $10.3K | $184.4K | -$36.8K | $180.1K | $22.0K | -$92.0K | -$387.9K | |||||
| Comprehensive Income Net Of Tax | $6.0M | $10.9M | $31.3M | $23.4M | $9.5M | $8.6M | $7.3M | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$6.8M | $8.6M | $9.8M | $20.8M | -$9.0M | -$10.2M | ||||||
| Income Taxes Paid Net | $20.6M | $16.2M | ||||||||||
| Deferred Income Taxes And Tax Credits | $7.0M | -$360.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity * | $248.3M | $195.1M | $142.2M | $107.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $163.8M | $125.0M | $103.0M | $51.7M |
| Retained Earnings Accumulated Deficit | $240.4M | $189.5M | $142.8M | -$3.4M |
| Liabilities And Stockholders Equity | $380.4M | $266.1M | $258.8M | $119.9M |
| Liabilities | $117.1M | $71.1M | $115.0M | $4.6M |
| Assets Current | $231.2M | $184.5M | $165.9M | $722.2K |
| Assets | $380.4M | $266.1M | $258.8M | $119.9M |
| Liabilities Current | $61.1M | $61.2M | $92.5M | $566.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $38.7M | $22.0M | $51.3M | |
| Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption To Redemption Amount | $2.0M | |||
| Repayments Of Related Party Debt | $145.9K | $739.4K | $7.7M | |
| Notes Payable Current | $0.00 | $26.3K | $3.4M | |
| Accounts Payable Current | $79.4K | |||
| Cash And Cash Equivalents At Carrying Value | $163.8M | $125.0M | $103.0M | $485.6K |
| Goodwill | $15.4M | $4.6M | $3.6M | |
| Franchise Taxes Payable Current | $161.6K | |||
| Deferred Compensation Liability Classified Noncurrent | $4.0M | |||
| Assets Held In Trust Noncurrent | $119.2M | |||
| Repayment Of Receivable From Others | -$83.7K | -$176.1K | -$581.3K | |
| Repayment Of Notes Receivable From Related Parties | $1.9M | $6.6M | $1.9M | |
| Remeasurement Of Operating Lease Liabilities And Rightofuse Assets Due To Lease Modifications | $5.3M | $2.9M | $2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $248.0M | $244.6M | $226.4M | $205.0M | $8.8M | $9.0M | -$5.6M | -$5.2M | -$3.7M | -$3.4M | -$3.2M | $23.4K | $24.7K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $127.4M | $152.7M | $132.1M | $137.4M | $103.7M | $96.2M | $77.4M | $974.9K | $217.3K | $580.0K | $179.4K | |||
| Retained Earnings Accumulated Deficit | $226.2M | $213.4M | $211.0M | $182.9M | -$6.6M | -$6.3M | -$5.6M | -$5.2M | -$3.7M | -$3.2M | -$1.6K | |||
| Liabilities And Stockholders Equity | $321.4M | $315.3M | $284.6M | $296.5M | $19.5M | $19.8M | $21.4M | $21.6M | $120.8M | $119.1M | $362.1K | |||
| Liabilities | $73.3M | $70.6M | $58.3M | $91.0M | $8.5M | $8.4M | $6.5M | $6.5M | $4.9M | $4.3M | $338.7K | |||
| Assets Current | $227.2M | $241.3M | $215.1M | $202.1M | $1.4M | $1.8M | $743.9K | $1.2M | $467.7K | $845.0K | $183.6K | |||
| Assets | $321.4M | $315.3M | $284.6M | $296.5M | $19.5M | $19.8M | $21.4M | $21.6M | $120.8M | $119.1M | $362.1K | |||
| Liabilities Current | $44.6M | $60.7M | $48.5M | $72.4M | $4.5M | $4.4M | $2.4M | $2.5M | $837.1K | $260.5K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $7.0M | -$6.8M | -$268.2K | $179.4K | ||||||||||
| Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption To Redemption Amount | -$152.6K | -$170.0K | $258.8K | -$669.1K | -$987.8K | $12.4M | ||||||||
| Repayments Of Related Party Debt | $16.1K | $9.9K | ||||||||||||
| Notes Payable Current | $1.6M | $3.3M | $1.4M | $10.2M | $2.7M | |||||||||
| Accounts Payable Current | $14.9M | $77.0K | $60.0K | $26.5M | $34.3K | $79.8K | $76.6K | $76.1K | ||||||
| Cash And Cash Equivalents At Carrying Value | $127.4M | $152.7M | $132.1M | $137.4M | $580.0K | $179.4K | ||||||||
| Goodwill | $4.9M | $5.0M | $4.8M | $3.5M | ||||||||||
| Franchise Taxes Payable Current | $15.5K | $43.3K | $73.0K | $57.6K | $42.3K | $50.0K | $125.8K | |||||||
| Deferred Compensation Liability Classified Noncurrent | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | |||||||
| Assets Held In Trust Noncurrent | $18.1M | $18.0M | $20.9M | $20.7M | $20.4M | $120.4M | $118.2M | |||||||
| Repayment Of Receivable From Others | -$30.7K | -$21.4K | ||||||||||||
| Repayment Of Notes Receivable From Related Parties | $70.0K | $215.0K | ||||||||||||
| Remeasurement Of Operating Lease Liabilities And Rightofuse Assets Due To Lease Modifications | $358.4K | $1.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $24.7M | $20.6M | $50.7M |
| Increase Decrease In Prepaid Expense | -$332.3K | $2.3M | -$4.1M |
| Net Cash Provided By Used In Investing Activities | -$21.0M | -$10.1M | $1.8M |
| Net Cash Provided By Used In Financing Activities | $38.3M | $23.0M | $6.1M |
| Increase Decrease In Accrued Income Taxes Payable | -$11.7M | $11.2M | $13.4M |
| Proceeds From Convertible Debt | -$1.4M | -$119.0K | $1.0M |
| Proceeds From Related Party Debt | $15.0K | $5.5M | $12.3M |
| Increase Decrease In Accounts Payable | -$35.5K | ||
| Payments To Fund Longterm Loans To Other | -$14.5K | -$172.4K | -$926.0K |
| Payments To Acquire Property Plant And Equipment | $1.4M | $2.6M | $8.5M |
| Increase Decrease In Other Operating Liabilities | $11.0K | $40.2K | $4.8K |
| Increase Decrease In Other Operating Assets | $195.8K | $1.7M | $1.3M |
| Increase Decrease In Other Accrued Liabilities | $3.0M | -$12.1M | $4.5M |
| Increase Decrease In Operating Lease Liability | -$4.9M | -$4.0M | -$3.2M |
| Increase Decrease In Longterm Prepayments | -$318.5K | -$1.9M | $3.5M |
| Increase Decrease In Leasing Receivables | $12.7M | $6.0M | -$16.6M |
| Increase Decrease In Inventories | $170.2K | -$1.1M | $1.8M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$3.3M | -$11.4M | -$7.3M |
| Depreciation Depletion And Amortization | $2.7M | $3.8M | $12.2M |
| Share Based Compensation | $0.00 | $13.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q2 2022 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $1.9M | $3.7M | -$393.8K | -$5.8K | ||
| Increase Decrease In Prepaid Expense | $3.2M | -$610.1K | $13.7K | $4.1K | ||
| Net Cash Provided By Used In Investing Activities | -$978.8K | -$3.4M | $125.6K | |||
| Net Cash Provided By Used In Financing Activities | -$280.4K | -$40.2K | $185.2K | |||
| Increase Decrease In Accrued Income Taxes Payable | -$17.6M | -$6.6M | $262.7K | |||
| Proceeds From Convertible Debt | -$55.9K | -$30.4K | ||||
| Proceeds From Related Party Debt | $15.0K | $300.0K | ||||
| Increase Decrease In Accounts Payable | $16.0K | -$2.8K | ||||
| Payments To Fund Longterm Loans To Other | -$12.8K | -$44.9K | ||||
| Payments To Acquire Property Plant And Equipment | $253.7K | $702.3K | ||||
| Increase Decrease In Other Operating Liabilities | -$98.0K | $3.0K | ||||
| Increase Decrease In Other Operating Assets | -$318.4K | $328.8K | ||||
| Increase Decrease In Other Accrued Liabilities | $63.8K | -$1.6M | ||||
| Increase Decrease In Operating Lease Liability | -$1.0M | -$1.1M | ||||
| Increase Decrease In Longterm Prepayments | -$98.2K | -$138.2K | ||||
| Increase Decrease In Leasing Receivables | $2.8M | $814.6K | ||||
| Increase Decrease In Inventories | $124.3K | $34.8K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $6.3M | -$7.1M | ||||
| Depreciation Depletion And Amortization | $628.3K | $1.0M | ||||
| Share Based Compensation | $0.00 | $12.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 103.0M | 96.6M | 94.2M | |
| Earnings Per Share Basic | $0.50 | $0.48 | $0.42 | |
| Weighted Average Number Of Diluted Shares Outstanding | 103.0M | 96.6M | 94.2M | |
| Earnings Per Share Diluted | $0.50 | $0.48 | $0.42 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 102.6M | 103.5M | 103.3M | 95.1M | 94.2M | 94.2M | 94.2M | 2.5M | |||
| Earnings Per Share Basic | $0.12 | $0.02 | $0.21 | $0.03 | $0.20 | $0.20 | $0.09 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 102.6M | 103.5M | 103.3M | 95.1M | 94.2M | 94.2M | 94.2M | ||||
| Earnings Per Share Diluted | $0.12 | $0.02 | $0.21 | $0.03 | $0.20 | $0.20 | $0.09 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Prepaid Expense Current | $10.1M | $236.6K | ||
| Additional Paid In Capital | $72.9M | $62.5M | $36.9M | |
| Franchise Tax Expenses | $137.4K | |||
| Investment Income Interest | $198.3K | $19.9K | $86.7K | |
| Investment Income Dividend | $2.6M | |||
| Provision For Other Credit Losses | $302.9K | -$402.2K | $370.8K | |
| Noncash Contribution Expense | $4.7M | $3.9M | $3.3M | |
| Interest Paid Net | $160.6K | $28.3K | $45.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Expense Current | $33.0M | $11.3M | $8.4M | $59.3K | $109.7K | $163.0K | $178.9K | $250.3K | $265.0K | $4.1K | ||
| Additional Paid In Capital | $72.2M | $72.2M | $62.5M | $15.4M | $15.3M | $24.7K | ||||||
| Franchise Tax Expenses | $41.1K | $42.0K | $40.4K | $42.5K | $14.0K | $125.8K | ||||||
| Investment Income Interest | $120.4K | $22.9K | $55.3K | $8.0K | $11.6K | $17.7K | $10.2K | |||||
| Investment Income Dividend | $234.0K | $257.3K | $266.2K | $836.9K | $1.3M | $350.9K | ||||||
| Provision For Other Credit Losses | $25.1K | $152.6K | ||||||||||
| Noncash Contribution Expense | $985.2K | $1.1M | ||||||||||
| Interest Paid Net | $6.2K | $3.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.